Hong Kong-based COVID-19 testing firm Prenetics buys ACT Genomics

Hong Kong-based COVID-19 testing firm Prenetics buys ACT Genomics

Visuals from Prenetics' official website

19 December, 2022

ACT Genomics cancer care Covid genomics oncology precision Prenetics

Printed by Unregistered user on Wed, 16 Jul 2025 01:46:10 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

HK's COVID-testing lab Prenetics to merge with Adrian Cheng's SPAC and list in the US

Investors bet on greed and fear as COVID grip loosens in China

Read more from Greater China

Sino Biopharmaceutical to acquire LaNova Medicines for up to $951m

Uber, Baidu team up to launch self-driving taxis in global markets